Abbott Laboratories buy Wells Fargo & Company
Start price
05.04.23
/
50%
€93.86
Target price
05.04.24
€124.25
Performance (%)
8.89%
End price
06.04.24
€102.20
Summary
This prediction ended on 06.04.24 with a price of €102.20. The BUY prediction by Wells_Fargo___Compan finished with a performance of 8.89%. Wells_Fargo___Compan has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. A total of €1.90 was paid as dividends for this prediction. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -0.218% | -0.218% | 0.219% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Wells Fargo & Company from $140.00 to $136.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€109.69
19.10.24
19.10.24
14.33%
16:00
16:00
